News

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...
Regeneron intends for 23andMe to continue its consumer genome services without interruption. The transaction, pending ...
The company, which was founded in 2006, rose to prominence by offering at-home DNA testing kits that allowed people to ...
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...
Regeneron is set to acquire 23andMe’s consumer genetics and research assets for $256 million. Here’s what the deal means for ...